First-in-Human Study of DNA Antibody Replicas Generate Efficient and Long-Lasting Biologic Production of Human Antiviral Antibodies

First-in-Human Study of DNA Antibody Replicas Generate Efficient and Long-Lasting Biologic Production of Human Antiviral Antibodies

A multidisciplinary team of scientists led by The Wistar Institute, including Perelman School of Medicine at the University of Pennsylvania, AstraZeneca and Inovio Pharmaceuticals, published today in Nature Medicine a breakthrough in biologic antibody production that happens directly in human subjects in this encouraging first clinical trial of its kind.

Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine